Interferons (IFs) and interleukins (ILs) are immune system biochemicals at the intersection of basic research and medical technology. Part of the class of secreted cellular regulators known as cytokines, IFs and ILs have experienced dizzying public relations ups and downs, hailed one season as tomorrow's wonder drugs, derided the next as toxic side effects emerge during therapy.
| With many questions about the basic biology of these enigmatic immunochemicals still to be answered, suppliers--some of whom are listed below--are likely to have a ready research market. |
Cellular Products Inc.
Cetus Oncology Corp.
R&D Systems Inc.
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?